AVEO Oncology
AVEO
#7209
Rank
NZ$0.88 B
Marketcap
NZ$25.51
Share price
0.00%
Change (1 day)
173.93%
Change (1 year)

Earnings for AVEO Oncology (AVEO)

Earnings in 2022 (TTM): -NZ$44.46 Million

According to AVEO Oncology 's latest financial reports the company's current earnings are NZ$94.31 Million. In 2021 the company made an earning of -NZ$90.71 Million a decrease over its 2020 earnings that were of -NZ$60.52 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AVEO Oncology from 2009 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -NZ$44.46 Million-50.99%
2021 -NZ$90.71 Million49.9%
2020 -NZ$60.52 Million-479.04%
2019 NZ$15.96 M-276.17%
2018 -NZ$9.07 Million-91.79%
2017 -NZ$0.12 Billion142.38%
2016 -NZ$45.55 Million78.51%
2015 -NZ$25.52 Million-71.55%
2014 -NZ$89.69 Million-50.72%
2013 -NZ$0.19 Billion-4.88%
2012 -NZ$0.2 Billion-426.29%
2011 NZ$58.64 M-159.85%
2010 -NZ$97.99 Million35.33%
2009 -NZ$72.41 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
NZ$43.75 B-88,708.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$15.26 B-31,010.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$2.64 B-5,460.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$8.89 B-18,112.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$15.86 B-32,222.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-NZ$3.85 Million-92.22%๐Ÿ‡บ๐Ÿ‡ธ USA